<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Genmab — April 2021]]></title><description><![CDATA[<p dir="auto">God morgen. <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=d361a5e1ce4" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/399147/genmab-april-2021</link><generator>RSS for Node</generator><lastBuildDate>Tue, 09 Jun 2026 07:00:48 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/399147.rss" rel="self" type="application/rss+xml"/><pubDate>Thu, 01 Apr 2021 03:46:24 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Genmab — April 2021 on Fri, 30 Apr 2021 10:37:59 GMT]]></title><description><![CDATA[<p dir="auto">Abbvie gør det godt <a href="https://finance.yahoo.com/news/abbvie-reports-first-quarter-2021-114200028.html" rel="nofollow ugc">https://finance.yahoo.com/news/abbvie-reports-first-quarter-2021-114200028.html</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639732</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639732</guid><dc:creator><![CDATA[Solsen]]></dc:creator><pubDate>Fri, 30 Apr 2021 10:37:59 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Fri, 30 Apr 2021 09:26:52 GMT]]></title><description><![CDATA[<p dir="auto">Q&amp;A<br />
<a href="https://www.proinvestor.com/index.php?p=q-and-a&amp;groupid=134" rel="nofollow ugc">https://www.proinvestor.com/index.php?p=q-and-a&amp;groupid=134</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639733</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639733</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Fri, 30 Apr 2021 09:26:52 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Fri, 30 Apr 2021 05:26:37 GMT]]></title><description><![CDATA[<p dir="auto">ref Sydbank - Looks reasonable with a surplus of the quarter around 380 mDKK primarily explained by milestones of 420 mDKK and around zero without the milestones.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639731</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639731</guid><dc:creator><![CDATA[deleted-user]]></dc:creator><pubDate>Fri, 30 Apr 2021 05:26:37 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Fri, 30 Apr 2021 05:24:08 GMT]]></title><description><![CDATA[<p dir="auto">Seattle Genetics (SGEN) Q1 2021 Earnings Call Transcript <a href="https://www.fool.com/earnings/call-transcripts/2021/04/30/seattle-genetics-sgen-q1-2021-earnings-call-transc/" rel="nofollow ugc">https://www.fool.com/earnings/call-transcripts/2021/04/30/seattle-genetics-sgen-q1-2021-earnings-call-transc/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639729</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639729</guid><dc:creator><![CDATA[E_L]]></dc:creator><pubDate>Fri, 30 Apr 2021 05:24:08 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Fri, 30 Apr 2021 05:06:49 GMT]]></title><description><![CDATA[<p dir="auto">Sydbankanalyse: Genmab fastholder formentlig prognosen – men opjustering senere på året er rykket tættere på <a href="https://ugebrev.dk/flashnews/sydbankanalyse-genmab-fastholder-formentlig-prognosen-men-opjustering-senere-paa-aaret-er-rykket-taettere-paa/" rel="nofollow ugc">https://ugebrev.dk/flashnews/sydbankanalyse-genmab-fastholder-formentlig-prognosen-men-opjustering-senere-paa-aaret-er-rykket-taettere-paa/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639735</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639735</guid><dc:creator><![CDATA[E_L]]></dc:creator><pubDate>Fri, 30 Apr 2021 05:06:49 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Fri, 30 Apr 2021 04:57:40 GMT]]></title><description><![CDATA[<p dir="auto">Go morgen. Tak for TA Stockbull..:)</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639730</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639730</guid><dc:creator><![CDATA[transalp]]></dc:creator><pubDate>Fri, 30 Apr 2021 04:57:40 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Fri, 30 Apr 2021 04:39:32 GMT]]></title><description><![CDATA[<p dir="auto">God morgen. <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=d361a5e1ce4" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639727</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639727</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Fri, 30 Apr 2021 04:39:32 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Fri, 30 Apr 2021 00:00:33 GMT]]></title><description><![CDATA[<p dir="auto">Genmab TA <a href="https://www.youtube.com/watch?v=DrzwzixLaYY" rel="nofollow ugc">https://www.youtube.com/watch?v=DrzwzixLaYY</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639725</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639725</guid><dc:creator><![CDATA[StockBull]]></dc:creator><pubDate>Fri, 30 Apr 2021 00:00:33 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Thu, 29 Apr 2021 12:43:59 GMT]]></title><description><![CDATA[<p dir="auto">Der nok ikke mange der satser på en lille god torsdags nyhed.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639724</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639724</guid><dc:creator><![CDATA[gdn55]]></dc:creator><pubDate>Thu, 29 Apr 2021 12:43:59 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Thu, 29 Apr 2021 12:39:42 GMT]]></title><description><![CDATA[<p dir="auto">Hmm - renten stiger igen</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639726</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639726</guid><dc:creator><![CDATA[JørgenVarnæs]]></dc:creator><pubDate>Thu, 29 Apr 2021 12:39:42 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Thu, 29 Apr 2021 10:20:46 GMT]]></title><description><![CDATA[<p dir="auto">Det sært at finde ud af hvad de forskellige analytikere og markedet har vurderet Haxa38 til men umidlbart tror jeg det er lidt - måske 50 kurs point eller mindre</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639728</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639728</guid><dc:creator><![CDATA[StockBull]]></dc:creator><pubDate>Thu, 29 Apr 2021 10:20:46 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Thu, 29 Apr 2021 09:42:31 GMT]]></title><description><![CDATA[<p dir="auto">Enig i argumentationerne fra Sukker, Solsen og Stockbull. Konflikten er indregnet og en af hovedårsagerne til kursen lige nu. Og der er ikke rigtig nogen der har indregnet Hexa38. At lide nederlag på alle fronter er absolut det mindst sandsynlige tror jeg</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639723</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639723</guid><dc:creator><![CDATA[Darvin]]></dc:creator><pubDate>Thu, 29 Apr 2021 09:42:31 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Thu, 29 Apr 2021 08:20:40 GMT]]></title><description><![CDATA[<p dir="auto">Vort første biotekarrangement er d. 11. maj med Scandion Oncology, Ascelia Pharma &amp; Hansa Biopharma</p>
<p dir="auto">Dato: 2021-05-11 Tid: 10:00 - 11:30 : Tilmelding: <a href="https://events.nordnet.dk/nordnet-events/kom-helt-taet-paa-tre-biotekvirksomheder-scandion-oncology-ascelia-pharma-hansa-biopharma/" rel="nofollow ugc">https://events.nordnet.dk/nordnet-events/kom-helt-taet-paa-tre-biotekvirksomheder-scandion-oncology-ascelia-pharma-hansa-biopharma/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639722</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639722</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Thu, 29 Apr 2021 08:20:40 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Thu, 29 Apr 2021 08:19:10 GMT]]></title><description><![CDATA[<p dir="auto">Tilmelding Nordnet: <a href="https://events.nordnet.dk/nordnet-events/kom-helt-taet-paa-tre-biotekvirksomheder-bavarian-zealand-pharma-genmab/" rel="nofollow ugc">https://events.nordnet.dk/nordnet-events/kom-helt-taet-paa-tre-biotekvirksomheder-bavarian-zealand-pharma-genmab/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639721</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639721</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Thu, 29 Apr 2021 08:19:10 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Thu, 29 Apr 2021 07:20:25 GMT]]></title><description><![CDATA[<p dir="auto">Helge Helt! Tak</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639720</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639720</guid><dc:creator><![CDATA[Svingtraderen]]></dc:creator><pubDate>Thu, 29 Apr 2021 07:20:25 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Thu, 29 Apr 2021 07:11:28 GMT]]></title><description><![CDATA[<p dir="auto">Godt gået Helge !</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639717</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639717</guid><dc:creator><![CDATA[Solsen]]></dc:creator><pubDate>Thu, 29 Apr 2021 07:11:28 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Thu, 29 Apr 2021 07:04:57 GMT]]></title><description><![CDATA[<p dir="auto">Q&amp;A er aftalt til d. 17. maj 15-15.45 med Jan. Dagen efter d. 18. har vi også sammen med Nordnet live arrangement med Genmab, Bavarian og Zealand Pharma.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639716</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639716</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Thu, 29 Apr 2021 07:04:57 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Thu, 29 Apr 2021 06:30:05 GMT]]></title><description><![CDATA[<p dir="auto">Kunne være godt at være fluen på vægen når GEN ledelsen diskutere patent issue. Gad vide om de har en fornemmelse<br />
hvor vej vinden blæser ?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639734</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639734</guid><dc:creator><![CDATA[monzi]]></dc:creator><pubDate>Thu, 29 Apr 2021 06:30:05 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Thu, 29 Apr 2021 06:25:49 GMT]]></title><description><![CDATA[<p dir="auto">we don't know yet if Hexa38 can be administered subcutaneously, but IF it is possible it will solve a few royalty<br />
issues...</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639714</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639714</guid><dc:creator><![CDATA[E_L]]></dc:creator><pubDate>Thu, 29 Apr 2021 06:25:49 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Thu, 29 Apr 2021 06:18:39 GMT]]></title><description><![CDATA[<p dir="auto">Helt enig Solsen</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639715</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639715</guid><dc:creator><![CDATA[GeorgeBest]]></dc:creator><pubDate>Thu, 29 Apr 2021 06:18:39 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Thu, 29 Apr 2021 06:00:59 GMT]]></title><description><![CDATA[<p dir="auto">Mht Hexa38 så vil de slå til, hvis data er signifikant bedre end dara. Det har hele tiden været klart. JNJ vil ikke spekulere i sparede royalty, hvis de ser at stoffet er bedre end dara af hensyn til at sikre sig markedet fremover. Vi vil hele tiden se konkurrenter arbejde på at finde stoffer der er bedre en dara og derfor skal JNJ udnytte enhver mulighed for at kvalitetsforbedre deres pipeline/drugs.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639712</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639712</guid><dc:creator><![CDATA[Solsen]]></dc:creator><pubDate>Thu, 29 Apr 2021 06:00:59 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Thu, 29 Apr 2021 05:56:58 GMT]]></title><description><![CDATA[<p dir="auto">Apropos Duobody: Janssen has exercised 14 licenses under this<br />
collaboration, not all of which are active, and no<br />
further options remain for use by Janssen. (fra årsrapporten)</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639713</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639713</guid><dc:creator><![CDATA[gentogen]]></dc:creator><pubDate>Thu, 29 Apr 2021 05:56:58 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Thu, 29 Apr 2021 05:51:41 GMT]]></title><description><![CDATA[<p dir="auto">Enig Solsen. Jeg tænker heller ikke en afgørelse får nævneværdi negativ indflydelse på selve samarbejdet. Udfaldet af voldgiften vil dog betyde specielt JnJ på ny skal regne på hvad der bedst kan svare sig mht hexa38</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639711</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639711</guid><dc:creator><![CDATA[troldmanden]]></dc:creator><pubDate>Thu, 29 Apr 2021 05:51:41 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — April 2021 on Thu, 29 Apr 2021 05:42:15 GMT]]></title><description><![CDATA[<p dir="auto">Husk at det er professionelle firmaer vi har med at gøre og ikke nabostridigheder i villakvateret. Det handler om penge og når det er afgjort er vi videre. Ret beset ved jeg ikke hvor meget samarbejde der længere er tilbage mellem Genmab og JNJ. JNJ kører dara suverænt og duobodysamarbejdet er sikkert mere eller mindre afsluttet med det arbejde der skulle udføres fra Genmabs side.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7639719</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7639719</guid><dc:creator><![CDATA[Solsen]]></dc:creator><pubDate>Thu, 29 Apr 2021 05:42:15 GMT</pubDate></item></channel></rss>